Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Respiratory Syncytial Viral (RSV) Infection”

101 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 101 results

Not applicableUnknownNCT00613184
What this trial is testing

Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses

Who this might be right for
Respiratory Syncytial VirusHuman MetapneumovirusInfluenza+2 more
Kern Medical Center 150
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Not applicableStudy completedNCT05268939
What this trial is testing

Performance Evaluation of LumiraDx SARS-CoV-2, Flu A/B, and RSV Tests for COVID-19 Assessment

Who this might be right for
COVID-19Influenza AInfluenza Type B+1 more
LumiraDx UK Limited 589
Early research (Phase 1)Study completedNCT02484417
What this trial is testing

Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers

Who this might be right for
Upper Respiratory Tract Infection
National Institute of Allergy and Infectious Diseases (NIAID) 32
Testing effectiveness (Phase 2)Study completedNCT02956837
What this trial is testing

Rank Different Dosages of Antigen of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3003891A), Based on Their Immune Response and Safety, When Administered to Healthy Adult Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 406
Not applicableNot Yet RecruitingNCT07813481
What this trial is testing

ELderly REspiratory VIral Cohort

Who this might be right for
Influenza VirusesRespiratory Syncytial Virus (RSV)Severe Acute Respiratory Syndrome Coronavirus 2+5 more
Assistance Publique - Hôpitaux de Paris 1,000
Not applicableUnknownNCT05277298
What this trial is testing

Household Study of COVID-19, Influenza and RSV Burden, Transmission Dynamics and Viral Interaction in South Africa

Who this might be right for
SARS-CoV-2 InfectionInfluenzaRespiratory Syncytial Virus (RSV)
National Institute for Communicable Diseases, South Africa 1,200
Testing effectiveness (Phase 2)Ended earlyNCT03715023
What this trial is testing

Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 5
Not applicableActive Not RecruitingNCT07816471
What this trial is testing

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more
Hospital Italiano de Buenos Aires 350
Not applicableWithdrawnNCT01098227
What this trial is testing

Exhaled Nitric Oxide Levels in Infants and Young Children Infected With RSV or Other Viral Infections

Who this might be right for
BronchiolitisInfectionNitric Oxide
NYU Langone Health
Not applicableStudy completedNCT07177508
What this trial is testing

First Year Impact of Nirsevimab on Paediatric Respiratory Syncytial Virus Infection and Hospitalisations in the Australian Capital Territory

Who this might be right for
Respiratory Syncytial Viral (RSV) InfectionRespiratory Syncytial Virus HospitalizationsRespiratory Syncytial Virus Prevention
Nicola Irwin 2,355
Not applicableActive Not RecruitingNCT05913700
What this trial is testing

Effect of Respiratory Virus Infection on EmeRgencY Admission Study (EVERY Study)

Who this might be right for
Respiratory Syncytial Virus (RSV)Respiratory Viral InfectionAcute Disease
Institute for Clinical Effectiveness, Japan 3,067
Not applicableStudy completedNCT04782336
What this trial is testing

Sample Collection Study to Aid Evaluation of an Influenza A/B, Respiratory Syncytial Virus & COVID-19 Virus POC Test

Who this might be right for
Covid19RSV InfectionInfluenza Type A+1 more
LumiraDx UK Limited 79
Early research (Phase 1)Study completedNCT02491463
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' RSV Investigational Vaccine (ChAd155-RSV) (GSK3389245A) in Healthy Adults

Who this might be right for
Respiratory Synctial Virus Infections
GlaxoSmithKline 73
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Not applicableLooking for participantsNCT07599449
What this trial is testing

Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

Who this might be right for
Respiratory Tract Infections (RTI)Influenza -Like IllnessInfluenza+4 more
Institut National de la Santé Et de la Recherche Médicale, France 25,000
Large-scale testing (Phase 3)Study completedNCT05330975
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥50 Years of Age

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 3,317
Not applicableStudy completedNCT05794412
What this trial is testing

Mucosal Immunity: Influence on Infectious Viral Load: a Prospective Observational Study

Who this might be right for
SARS-CoV-2 InfectionInfluenza Viral InfectionsVirus Shedding+2 more
University Hospital, Geneva 320
Testing effectiveness (Phase 2)Study completedNCT03303625
What this trial is testing

Evaluate the Safety, Tolerability and Immunogenicity of an Investigational RSV Vaccine Candidate (Ad26.RSV.preF) in Adults 18 to 50 Years of Age, and RSV-seropositive Toddlers 12 to 24 Months of Age

Who this might be right for
Respiratory Syncytial VirusesRespiratory Tract Infections
Janssen Vaccines & Prevention B.V. 48
Very early researchStudy completedNCT05148780
What this trial is testing

Acute Respiratory Infections in Global Outpatient Setting

Who this might be right for
Acute Respiratory Infection
Janssen Research & Development, LLC 245
Next Page